ATLAS / Macro Radar / Reporting / IBO

IMPACT BIOMEDICAL INC. (IBO) reporting calendar

IMPACT BIOMEDICAL INC. files periodic reports with the SEC as IBO on NYSE. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
20 Jul 2026 – 6 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
12

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open IBO market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll NYSE reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001493152-26-022512
10-K31 Dec 202511 Mar 202670 days0001493152-26-009711
10-Q30 Sep 20257 Nov 202538 days0001493152-25-021286
10-Q30 Jun 202514 Aug 202545 days0001641172-25-023809
10-Q31 Mar 202514 May 202544 days0001641172-25-010276
10-K31 Dec 202428 Mar 202587 days0001641172-25-001199
10-Q30 Sep 202412 Nov 202443 days0001493152-24-044792
10-Q30 Jun 202413 Aug 202444 days0001493152-24-031635
10-Q31 Mar 202410 May 202440 days0001493152-24-018663
10-K31 Dec 202320 Feb 202451 days0001493152-24-007229
10-Q30 Sep 202313 Nov 202344 days0001493152-23-040547
10-Q30 Jun 20235 Oct 202397 days0001493152-23-036365

Source: SEC EDGAR company submissions for CIK 0001834105. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.